-
Xu Jinghe attends Global Harmonization Working Party annual meeting
2024-12-23
Xu Jinghe, deputy commissioner of China's National Medical Products Administration, attended the 28th annual meeting of the Global Harmonization Working Party (GHWP) and the 28th GHWP Technical Committee Meeting, which were held in Kuala Lumpur, capital of Malaysia, from Dec 9 to 12.
-
NMPA to enhance cooperation with drug regulatory authorities of Vietnam, Thailand
2024-11-22
Li Li, commissioner of China's National Medical Products Administration (NMPA), led a delegation to visit Vietnam and Thailand from Nov 11 to 15 to discuss practical cooperation in drug regulation with related departments.
-
Experts stress good personal hygiene, vaccination as respiratory illnesses rise
2024-11-22
Since the risk of respiratory infectious disease has increased as temperatures drop, experts emphasized the importance of maintaining good personal hygiene and getting vaccinated promptly.
-
China, Saudi Arabia sign MoU on drug regulation
2024-11-12
Li Li, commissioner of China's National Medical Products Administration (NMPA), signed a memorandum of understanding (MoU) on cooperation with Hisham S Aljadhey, chief executive officer of the Saudi Food and Drug Authority (SFDA), on Nov 1 in Beijing, to further enhance bilateral exchanges and cooperation in drug regulation.
-
NMPA signs letter of intent on cooperation with Danish Medicines Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices in Beijing on Oct 24.
-
Li Li meets with head of Brazil’s Health Regulatory Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Antonio Barra Torres, head of Brazil's Health Regulatory Agency (Anvisa), in Beijing on Oct 21.
